Aktienanalyse zu Roper Technologies Inc (ROP)ROPRoper Technologies Inc

Roper Technologies, Inc. is a diversified technology company. It operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The Company operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories. It operates in the Technology sector (INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, A industry).

Roper Technologies Inc is a good buy right now, primarily due to its current price of $364.09, which is significantly lower than the analyst price target of $450, suggesting a potential upside of about 23.5%. Additionally, the company has shown strong earnings growth, with a recent EPS of 11.62 in Q2 2026, reflecting a robust net margin of 55.41%. The main risk is the current debt to equity ratio of 60.53%, which indicates a higher level of debt compared to equity, potentially impacting financial stability.

13 analysts cover ROP: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 558.36.